ADAR1 Capital Management Calls for Keros Board to Collaborate on Company Strategy ADAR1 Capital Management, the largest stockholder of Keros Therapeutics, urges the Board to engage on strategy and capital allocations.

ADAR1 Capital Management Calls for Keros Board to Collaborate on Company Strategy #United_States #Austin #Board_of_Directors #Keros_Therapeutics #ADAR1_Capital

ADAR1 Critiques Keros Therapeutics' Director Election and Capital Return Strategy ADAR1 Capital Management expresses strong concerns about Keros Therapeutics' recent director election results and capital return plans while advocating for more shareholder-focused strategies.

ADAR1 Critiques Keros Therapeutics' Director Election and Capital Return Strategy #United_States #Austin #Keros_Therapeutics #ADAR1_Capital #Director_Election

ADAR1 Encourages Keros Therapeutics Shareholders to Reconsider Directors Amid Governance Concerns ADAR1 urges Keros Therapeutics shareholders to withhold votes for directors due to governance issues as outlined by ISS recommendations.

ADAR1 Encourages Keros Therapeutics Shareholders to Reconsider Directors Amid Governance Concerns #USA #Austin #Keros_Therapeutics #ISS_Recommendations #ADAR1_Capital

ADAR1 Capital Management Proposes Vote Withholding for Keros Therapeutics Directors ADAR1 Capital Management, the largest shareholder of Keros Therapeutics, plans to withhold votes for two board members at the upcoming meeting.

ADAR1 Capital Management Proposes Vote Withholding for Keros Therapeutics Directors #United_States #Austin #Keros_Therapeutics #ADAR1_Capital #Dr._Mary_Ann_Gray

ADAR1 Capital Management Urges Keros Therapeutics to Restructure in Open Letter to Shareholders ADAR1 Capital Management expresses significant concerns over Keros Therapeutics' underperformance and calls for management restructuring in an open letter to shareholders.

ADAR1 Capital Management Urges Keros Therapeutics to Restructure in Open Letter to Shareholders #USA #Austin #Stockholders #Keros_Therapeutics #ADAR1_Capital